AMI
H-FABP TRT
care H-FABP test
H-FABP True Rapid Test
adoption of H
emergency care
project FABPulous
objective test
rapid exclusion of Acute Myocardial Infarction
point
physician
mln revenue
primary
large proportion of patients
mln tests
diagnosis of acute myocardial infarction
medical device company
ultra-rapid diluted plasma preparation
medical guidelines
cardiac complaints
healthcare professionals
sustainable healthcare
chest pain complaints
number of unnecessary hospital referrals
heart-type fatty acid binding protein
amounts
Belgium
Netherlands
admissions
year
improvement
UK
innovative proprietary technology
NW Europe
current technologies
request
reimbursement
order
addressable market
great advantages
basis
drop of blood
production process
gross margin
SME
HCPs
medico
phased introduction plan
Maastricht University
health insurers
costs
pressing need
cost price
studies
occurrence
use
high level of confidence
home testing
clinical trials
Outcomes
core
population
inspection
Validation
biomarker
majority
cases